Endpoints News

Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

Outpace Bio, a Seattle-based biotech that aims to create cell therapies, has cemented its presence in the Emerald City with a new facility and a pair of local research partnerships with scientific leaders.

Read More

Outpace in the Press

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

October 31, 2023

Public Relations

Globe Newswire

Outpace Bio to present new data on tumor-restricted IL-12 designed leveraging OutSmart technology to enhance solid tumor T cell therapies at SITC 2023

READ MORE

READ MORE

DOWNLOAD

PR

October 9, 2023

Publications

Cancer Cell

Building smart CAR T cell therapies: The path to overcome current challenges

READ MORE

READ MORE

DOWNLOAD

Publications

August 2, 2023

In The News

GeekWire

Seattle startups move into growing science cluster in South Lake Union

READ MORE

READ MORE

DOWNLOAD

News

August 1, 2023

Publications

American Society for Gene & Cell Therapy (ASGCT)

OutSmart™ IL-2/15 Safely Stimulates CAR T Proliferation and Persistence in the Tumor while Limiting Regulatory T Cell Activation

READ MORE

READ MORE

DOWNLOAD

Publications

July 10, 2023

In The News

GeekWire

How AI is changing the way scientists engineer drugs, biosensors, enzymes and more

READ MORE

READ MORE

DOWNLOAD

News

May 26, 2023

In The News

Endpoints News

Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

READ MORE

READ MORE

DOWNLOAD

News

May 22, 2023

Public Relations

Globe Newswire

Outpace Bio expands Seattle presence with cell therapy research hub & collaborations with leading experts in protein design & cancer immunotherapy

READ MORE

READ MORE

DOWNLOAD

PR

May 18, 2023

Public Relations

Globe Newswire

Outpace Bio to present new data on OutSmart™ IL-2/15, a CAR T cell-produced designed cytokine with tumor-localized immune cell activity, at the 2023 annual meeting of the American Society of Gene & Cell Therapy (ASGCT)

READ MORE

READ MORE

DOWNLOAD

PR

All

All

News

PR

Publications

October 31, 2023

Public Relations

Globe Newswire

Outpace Bio to present new data on tumor-restricted IL-12 designed leveraging OutSmart technology to enhance solid tumor T cell therapies at SITC 2023

PR

October 9, 2023

Publications

Cancer Cell

Building smart CAR T cell therapies: The path to overcome current challenges

Publications

August 2, 2023

In The News

GeekWire

Seattle startups move into growing science cluster in South Lake Union

News

August 1, 2023

Publications

American Society for Gene & Cell Therapy (ASGCT)

OutSmart™ IL-2/15 Safely Stimulates CAR T Proliferation and Persistence in the Tumor while Limiting Regulatory T Cell Activation

Publications

July 10, 2023

In The News

GeekWire

How AI is changing the way scientists engineer drugs, biosensors, enzymes and more

News

May 26, 2023

In The News

Endpoints News

Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

News

August 2, 2023

In The News

GeekWire

Seattle startups move into growing science cluster in South Lake Union

News

July 10, 2023

In The News

GeekWire

How AI is changing the way scientists engineer drugs, biosensors, enzymes and more

News

May 26, 2023

In The News

Endpoints News

Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

News

May 11, 2023

In The News

BioCentury

Keeping up with the protein designers

News

June 28, 2022

In The News

GeekWire

Biotech startups join AWS and other partners in open-source project to help design new proteins

News

February 21, 2022

In The News

Fred Hutch Cancer Center

Red Light, Green Light: Precise cell targeting with Co-LOCKR

News

October 31, 2023

Public Relations

Globe Newswire

Outpace Bio to present new data on tumor-restricted IL-12 designed leveraging OutSmart technology to enhance solid tumor T cell therapies at SITC 2023

PR

May 22, 2023

Public Relations

Globe Newswire

Outpace Bio expands Seattle presence with cell therapy research hub & collaborations with leading experts in protein design & cancer immunotherapy

PR

May 18, 2023

Public Relations

Globe Newswire

Outpace Bio to present new data on OutSmart™ IL-2/15, a CAR T cell-produced designed cytokine with tumor-localized immune cell activity, at the 2023 annual meeting of the American Society of Gene & Cell Therapy (ASGCT)

PR

May 9, 2023

Public Relations

Globe Newswire

Outpace Bio, a leader in protein design for cell therapy, announces presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

PR

May 4, 2023

Public Relations

Globe Newswire

Outpace Bio, a leader in protein design for cell therapy, strengthens executive leadership team with key appointments

PR

March 23, 2023

Public Relations

Globe Newswire

Outpace Bio, a leader in protein design & cell engineering, adds Bahija Jallal to Board of Directors

PR

October 9, 2023

Publications

Cancer Cell

Building smart CAR T cell therapies: The path to overcome current challenges

Publications

August 1, 2023

Publications

American Society for Gene & Cell Therapy (ASGCT)

OutSmart™ IL-2/15 Safely Stimulates CAR T Proliferation and Persistence in the Tumor while Limiting Regulatory T Cell Activation

Publications

May 18, 2023

Publications

Molecular Therapy

OutSmart™ IL-2/15: A CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity

Publications

November 7, 2022

Publications

Journal for Immunotherapy of Cancer

Tuning the cell-cell distance via the non-signaling extracellular spacer domain of chimeric antigen receptors is critical for optimal activity

Publications

October 11, 2022

Publications

Frontiers in Molecular Medicine

Safety switch optimization enhances antibody-mediated elimination of CAR T cells

Publications

Press Kit

The Outpace Press Kit is designed to help journalists research Outpace. Please contact our communications team if you need more information or to schedule an interview.

Download